84.22.Z - Defence activities
71.2 - Technical testing and analysis
72.1 - Research and experimental development on natural sciences and engineering
72.2 - Research and experimental development on social sciences and humanities
74 - Other professional, scientific and technical activities
84.22 - Defence activities
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.9 - Other human health activities
96.09 - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,6 | 1 | 6,3 | 554,4 |
EBITDA | 9,6 | 7,9 | 13,7 | 72,8 |
Short time liabilities | 5,8 | 6,1 | 11,3 | 85 |
Equity capital | 74,2 | 74,7 | 80,3 | 7,5 |
Operating profit (EBIT) | 3,6 | 0,9 | 6,2 | 561,4 |
Assets | 148,1 | 151,3 | 184,4 | 21,9 |
Net profit (loss) | 3,3 | 0,8 | 5,7 | 600,5 |
Cash | 14,1 | 15,5 | 29,3 | 89,2 |
Net income from sale | 55,6 | 60,4 | 80,2 | 32,9 |
Liabilities and provisions for liabilities | 73,8 | 76,6 | 104,1 | 35,9 |
Working assets | 23,2 | 27,7 | 42,9 | 55,2 |
Depreciation | 5,9 | 7 | 7,5 | 7,4 |
% | % | % | p.p. | |
Profitability of capital | 4,4 | 1,1 | 7,2 | 6,1 |
Equity capital to total assets | 50,1 | 49,4 | 43,5 | -5,9 |
Gross profit margin | 6,5 | 1,6 | 7,8 | 6,2 |
EBITDA Margin | 17,3 | 13,1 | 17,1 | 4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 37 | 51 | 14 |
Current financial liquidity indicator | 0.3395402729511261 | 0.39195504784584045 | 0.4507090747356415 | 0,1 |
Net dept to EBITDA | -1.473362922668457 | -1.9555648565292358 | -2.1406126022338867 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane